Molecular Biomarkers Associated with Inflammatory and Fibrotic Pathways in Chronic Liver Disease: A Systematic Review
Objective: Chronic liver disease (CLD) is driven by chronic inflammation and progressive fibrosis, resulting in cirrhosis and hepatocellular carcinoma. Molecular biomarkers may enable non-invasive diagnosis, prognostication, and therapeutic targeting, but comprehensive synthesis remains limited. This systematic review...